Farnesyl transferase inhibition in hematologic malignancies

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


Farnysylated proteins are involved in adverse cell processes, and inhibition of farnesyl transferase offers an attractive target for oncology therapy. This discussion provides background information on the mechanism of action of farnesyl transferase inhibition and summarizes the available clinical data.

Original languageEnglish (US)
Pages (from-to)S-37-S-40
JournalJNCCN Journal of the National Comprehensive Cancer Network
Issue numberSUPPL. 1
StatePublished - Nov 1 2005


  • Carcinoma
  • Farnesyl transferase inhibition
  • Hematologic malignancies
  • Signal transduction

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Farnesyl transferase inhibition in hematologic malignancies'. Together they form a unique fingerprint.

Cite this